Rivaroxaban Viatris 15 mg, Filmtabletten - 28 Swissmedic Key 69319005 Registration Holder Viatris Pharma GmbH Name Rivaroxaban Viatris 15 mg, Filmtabletten Date of registration 19.10.2023 Original/Generic Generic Introduction of Sequence 19.10.2023 ATC-Classification Rivaroxaban (B01AF01) Revision date WHO WHO-DDD Valid until 18.10.2028 Index Therapeuticus (BSV) 06.03.40. Show package size 28 Index Therapeuticus (Swissmedic) 06.03. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 14.08 Limitation Yes Limitation text
Deductible 10 % Consumer price 32.00 Feedback FB Daily cost GTIN 7680693190054 Medication Code Synthetika Pharmacode Disponibility ●
Composition rivaroxabanum 15 mg, cellulosum microcristallinum, lactosum monohydricum 30.375 mg, carmellosum natricum conexum, hypromellosum, natrii laurilsulfas, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 171, E 172 (rubrum), pro compresso obducto corresp. natrium 0.340 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Rivaroxabanum 15 mg
BAG: Active Agent Dose Rivaroxabanum 15 mg
Inactive agents Dose additional_information (Rubrum) Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. E 172 color. Hypromellosum Lactose Monohydrate 30.375 mg Macrogol 3350 Magnesii Stearas Natrii Laurilsulfas Poly(Alcohol Vinylicus) Überzug Pro Compresso Obducto Talcum
Source Data was imported : 09.01.2026
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
